Researchers at Karolinska Institutet in Sweden have identified eight primary factors that increase the risk of a common bleeding complication
Continue reading »
mypharmacynews.com
Home »
Researchers at Karolinska Institutet in Sweden have identified eight primary factors that increase the risk of a common bleeding complication
Continue reading »NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. RAMACE® Ramipril Consumer Medicine Information What is
Continue reading »NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CELAPRAM contains the active ingredient citalopram hydrobromide
Continue reading »NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. BEOVU® This medicine is subject to additional
Continue reading »NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CODAPANE FORTE Consumer Medicine Information (CMI) summary
Continue reading »NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. IMATINIB-TEVA® CMI VERSION 2.0 Imatinib (as mesilate)
Continue reading »NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-TERBINAFINE Terbinafine hydrochloride Consumer Medicine Information What
Continue reading »NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MARVELON® 28 (mar-ve-lon) Ethinylestradiol and Desogestrel Consumer
Continue reading »NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TRENTAL® 400 Pentoxifylline (Oxpentifylline) Consumer Medicine Information
Continue reading »NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. RAPAMUNE® Sirolimus Oral Solution Consumer Medicine Information
Continue reading »